Dexlansoprazole
15 NDCs across 5 manufacturers|12 Generic,3 Brand
Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jan 30, 2009, and the first generic was approved Apr 19, 2017. FDA's Orange Book lists 10 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.
Dexlansoprazole is available as 15 NDCs from 5 manufacturers (12 generic, 3 brand), with NADAC prices from $3.71 to $9.85 per EA — the most expensive product costs about 2.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
15
12G / 3B
Manufacturers
5
competing in market
Price Spread
$3.71 – $9.85
per EA
7d Activity
avg -0.6% WoW · of 15 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Takeda Pharmaceuticals America, Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Proton Pump Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
5 manufacturers producing DEXLANSOPRAZOLE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
DEXILANT DR 30 MG CAPSULE | $9.8526 per EA | +0.01% |
DEXILANT DR 60 MG CAPSULE | $9.8394 per EA | -0.01% |
DEXILANT DR 60 MG CAPSULE | $9.8394 per EA | -0.01% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.7727 per EA | -4.88% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.7727 per EA | -4.88% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.7727 per EA | -4.88% |
DEXLANSOPRAZOLE DR 30 MG CAP | $3.7727 per EA | -4.88% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
DEXLANSOPRAZOLE DR 60 MG CAP | $3.7069 per EA | +1.37% |
Frequently Asked Questions
What is Dexlansoprazole used to treat?
Dexlansoprazole is used to treat peptic esophagitis, gastroesophageal reflux and heartburn, per the National Library of Medicine's MED-RT classification.
When did Dexlansoprazole become available as a generic?
FDA approved the first generic Dexlansoprazole (ANDA) on Apr 19, 2017. The Orange Book currently lists 10 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dexlansoprazole?
In 2024, Medicare Part D spent $262 million on Dexlansoprazole across 883,000 claims for 196,000 beneficiaries.
How many Dexlansoprazole products are on the market?
The Dexlansoprazole drug market contains 15 NDCs from 5 manufacturers — 12 generic and 3 brand products.
What is the price range for Dexlansoprazole?
NADAC reference prices for Dexlansoprazole range from $3.7069 to $9.8526 per EA — the most expensive product costs about 2.7× the cheapest.
Is generic Dexlansoprazole cheaper than brand?
The average generic NADAC for Dexlansoprazole is $3.7288 per EA, versus $9.8438 for brand-labeled products — brand versions average about 2.6× the generic price.
Which manufacturers make Dexlansoprazole?
5 manufacturers list Dexlansoprazole in NADAC. Ranked by number of NDCs, the largest are Takeda Pharmaceuticals America, Inc. (3), Mylan Pharmaceuticals Inc. (3), Upsher-Smith Laboratories LLC (3), Endo USA Inc. (3), Alembic Pharmaceuticals Inc. (3).
How has the price of Dexlansoprazole changed recently?
Over the past 7 days, 9 Dexlansoprazole NDCs rose and 6 fell, with a market-wide average change of -0.6%.